The role of astrocytes in amyloid β-protein toxicity and clearance

Akiyama, 1996, Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein, Neurosci. Lett., 206, 169, 10.1016/S0304-3940(96)12474-5 Alafuzoff, 1987, Blood–brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study, Acta Neuropathol., 73, 160, 10.1007/BF00693782 Bechmann, 2007, What is the blood–brain barrier (not)?, Trends Immunol., 28, 5, 10.1016/j.it.2006.11.007 Bruinsma, 2010, Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1–40)-mediated cell death, Brain Res., 1315, 169, 10.1016/j.brainres.2009.12.039 Calhoun, 1999, Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid, Proc. Natl. Acad. Sci. U.S.A., 96, 14088, 10.1073/pnas.96.24.14088 Carare, 2008, Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology, Neuropathol. Appl. Neurobiol., 34, 131, 10.1111/j.1365-2990.2007.00926.x Carpentier, 2002, Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy, J. Neuropathol. Exp. Neurol., 61, 849, 10.1093/jnen/61.10.849 Craft, 2004, Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo, Neurobiol. Aging, 25, 1283, 10.1016/j.neurobiolaging.2004.01.006 Cramer, 2012, ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models, Science, 335, 1503, 10.1126/science.1217697 Deane, 2008, apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain, J. Clin. Invest., 118, 4002, 10.1172/JCI36663 Dickson, 1988, Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques, Am. J. Pathol., 132, 86 Dorfman, 2010, Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease, Neurobiol. Aging, 31, 1743, 10.1016/j.neurobiolaging.2008.09.016 Farris, 2003, Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo, Proc. Natl. Acad. Sci. U.S.A., 100, 4162, 10.1073/pnas.0230450100 Funato, 1998, Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain, Am. J. Pathol., 152, 983 Games, 1995, Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein, Nature, 373, 523, 10.1038/373523a0 Glenner, 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 Griffin, 1989, Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 86, 7611, 10.1073/pnas.86.19.7611 Han, 1994, Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study, J. Neuropathol. Exp. Neurol., 53, 535, 10.1097/00005072-199409000-00013 Herz, 1988, Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor, EMBO J., 7, 4119, 10.1002/j.1460-2075.1988.tb03306.x Huang, 2001, Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons, Proc. Natl. Acad. Sci. U.S.A., 98, 8838, 10.1073/pnas.151254698 Hyman, 2012, National Institute on Aging—Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease, Alzheimers Dement., 8, 1, 10.1016/j.jalz.2011.10.007 Iwata, 2000, Identification of the major Abeta1–42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition, Nat. Med., 6, 143, 10.1038/77399 Koistinaho, 2004, Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides, Nat. Med., 10, 719, 10.1038/nm1058 Lan, 2011, Methyl salicylate 2-O-beta-D-lactoside, a novel salicylic acid analogue, acts as an anti-inflammatory agent on microglia and astrocytes, J. Neuroinflammation, 8, 98, 10.1186/1742-2094-8-98 Mahley, 1988, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science, 240, 622, 10.1126/science.3283935 Masters, 1985, Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proc. Natl. Acad. Sci. U.S.A., 82, 4245, 10.1073/pnas.82.12.4245 Moestrup, 1992, Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues, Cell Tissue Res., 269, 375, 10.1007/BF00353892 Mulder, 2012, The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes, Exp. Neurol., 233, 373, 10.1016/j.expneurol.2011.11.001 Nielsen, 2010, Astrocytic A beta 1–42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins, Glia, 58, 1235, 10.1002/glia.21004 Noble, 2011, Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury, Neurotherapeutics, 8, 677, 10.1007/s13311-011-0071-z Pitas, 1987, Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins, Biochim. Biophys. Acta, 917, 148, 10.1016/0005-2760(87)90295-5 Rolyan, 2011, Amyloid-beta protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease, J. Neural Transm., 118, 699, 10.1007/s00702-010-0572-7 Sadowski, 2004, A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice, Am. J. Pathol., 165, 937, 10.1016/S0002-9440(10)63355-X Schmechel, 1993, Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 90, 9649, 10.1073/pnas.90.20.9649 Sheng, 1997, Glial–neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages, J. Neuropathol. Exp. Neurol., 56, 285, 10.1097/00005072-199703000-00007 Sperling, 2011, Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement., 7, 280, 10.1016/j.jalz.2011.03.003 Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 90, 1977, 10.1073/pnas.90.5.1977 Strittmatter, 1993, Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 90, 8098, 10.1073/pnas.90.17.8098 Sturchler-Pierrat, 1997, Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology, Proc. Natl. Acad. Sci. U.S.A., 94, 13287, 10.1073/pnas.94.24.13287 Thal, 2009, The pre-capillary segment of the blood–brain barrier and its relation to perivascular drainage in Alzheimer's disease and small vessel disease, Scientific World Journal, 9, 557, 10.1100/tsw.2009.72 Thal, 2000, Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex, Acta Neuropathol., 100, 608, 10.1007/s004010000242 Thal, 2007, Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice, Neurobiol. Aging, 28, 1221, 10.1016/j.neurobiolaging.2006.05.029 Thal, 2010, Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease, Acta Neuropathol., 120, 169, 10.1007/s00401-010-0707-9 Utter, 2008, Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes, J. Neuropathol. Exp. Neurol., 67, 842, 10.1097/NEN.0b013e3181836a71 Weller, 1998, Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease, Am. J. Pathol., 153, 725, 10.1016/S0002-9440(10)65616-7 Weller, 2009, Lymphatic drainage of the brain and the pathophysiology of neurological disease, Acta Neuropathol., 117, 1, 10.1007/s00401-008-0457-0 Wilhelmus, 2007, Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells, Am. J. Pathol., 171, 1989, 10.2353/ajpath.2007.070050 Wyss-Coray, 2003, Adult mouse astrocytes degrade amyloid-beta in vitro and in situ, Nat. Med., 9, 453, 10.1038/nm838 Yamaguchi, 1998, Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques, Acta Neuropathol., 95, 217, 10.1007/s004010050790 Yin, 2006, Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism, J. Neurosci., 26, 10939, 10.1523/JNEUROSCI.2085-06.2006 Zhao, 2011, The contribution of activated astrocytes to Abeta production: implications for Alzheimer's disease pathogenesis, J. Neuroinflammation, 8, 150, 10.1186/1742-2094-8-150 Zlokovic, 2008, The blood–brain barrier in health and chronic neurodegenerative disorders, Neuron, 57, 178, 10.1016/j.neuron.2008.01.003 Zlokovic, 1996, Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood–brain and blood–cerebrospinal fluid barriers, Proc. Natl. Acad. Sci. U.S.A., 93, 4229, 10.1073/pnas.93.9.4229